CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Shionogi Inc. v. Aurobindo Pharma Ltd.

1:17-cv-00072

Overview

Case Number 1:17-cv-00072
Filing Date 2017-01-25
Status Terminated
Termination Date 2020-11-18
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:0145
Jury Demand None

Parties

Defendant

Qingdao Baheal Pharmaceutical Co. Ltd. Operating Company

Represented By

1 Attorneys Listed

Kenneth Laurence Dorsney

Morris James LLP

Tel: +1 (302) 888-6855
Fax: +1 (302) 571-1750

500 Delaware Avenue, Suite 1500, P.O. Box 2306

Aurobindo Pharma Ltd. Operating Company

Represented By

2 Attorneys Listed

Steven J. Moore

Email: steven.moore@withersworldwide.com

Arthur G. Connolly , III

Connolly Gallagher LLP

Tel: +1 (302) 757-7300

1201 North Market Street, 20th Floor, Wilmington, DE 19801

Aurobindo Pharma USA, Inc. Operating Company

Represented By

2 Attorneys Listed

Steven J. Moore

Email: steven.moore@withersworldwide.com

Arthur G. Connolly , III

Connolly Gallagher LLP

Tel: +1 (302) 757-7300

1201 North Market Street, 20th Floor, Wilmington, DE 19801

Plaintiff

Shionogi Inc. Operating Company

Represented By

3 Attorneys Listed

David P. Yin

Email: david.yin@wilmerhale.com

Sara E. Bussiere

UNDELIVERABLE EMAIL 5/28/2021

Tel: +1 (302) 655-5000

Stephen B. Brauerman

Bayard, P.A.

Tel: +1 (302) 655-5000
Fax: +1 (302) 658-6395

Bayard, P.A., 600 N. King Street

Counter Claimant

Andrx Labs, L.L.C. Operating Company

Represented By

2 Attorneys Listed

Sara E. Bussiere

UNDELIVERABLE EMAIL 5/28/2021

Tel: +1 (302) 655-5000

Stephen B. Brauerman

Bayard, P.A.

Tel: +1 (302) 655-5000
Fax: +1 (302) 658-6395

Bayard, P.A., 600 N. King Street

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 11 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials 3 proceedings
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (11): πŸ‡¨πŸ‡¦ Canada πŸ‡ͺπŸ‡Ί Europe πŸ‡―πŸ‡΅ Japan KR πŸ‡ΊπŸ‡Έ US 🌐 PCT
Parallel Proceedings Across Jurisdictions (3 found):
PTAB: 3
USPTO PTAB Trial 2018-01-24
IPR2018-00530

Aurobindo Pharma USA Inc. v. Andrx Labs, LLC et al.

Asserted Patent
Status: Institution Denied
USPTO PTAB Trial 2017-06-23
IPR2017-01673

Aurobindo Pharma USA Inc. et al. v. Andrx Labs, LLC et al.

Asserted Patent
Status: Institution Denied
USPTO PTAB Trial 2017-06-22
IPR2017-01648

Aurobindo Pharma USA Inc. et al. v. Andrx Labs, LLC et al.

U.S. Continuation Sibling (6866866)
Status: Final Written Decision
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

2 Patents

There are 2 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US6790459
Methods for treating diabetes via administration of controlled release metformin
Filed: 2000-11-03
Issued: 2004-09-14
Expired (Term Ended) +134d PTA
Expires: 2021-03-17
US6866866
Controlled release metformin compositions
Filed: 2000-11-03
Issued: 2005-03-15
Expired (Term Ended) +162d PTA
Expires: 2021-04-14

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting truncation noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

33

Dispositive

11

Granted

6

Denied

2

Pending / Review

22

Motions by Category

Motion to Dismiss 11 Procedural / Extension Motion 12 Claim Construction / Markman Filing 3 Motion to Strike / Sanctions 7

Key Dispositive Motions & Rulings

Motion to Dismiss Pending / Under Review
Copy of ORDER issued in 17cv1347 dismissing all claims and counterclaims between Plaintiff Shionogi, Inc., and Andrx Labs, LLC, and Defendant Qingdao Baheal Pha...
Entry #113 • 2019-01-23 Document →
Motion to Dismiss Pending
CORRECTING ENTRY: D.I. 103 Order approving D.I. 101 Motion to Dismiss Based upon Stipulated Motion for Dismissal with Prejudice was filed in error and removed f...
Entry #β€” • 2018-11-27
Motion to Dismiss Pending / Under Review
MOTION to Dismiss Based upon Stipulated Motion for Dismissal with Prejudice - filed by Shionogi Inc.. (Attachments: # 1 Text of Proposed Order Proposed Order of...
Entry #101 • 2018-11-08 Document →
Motion to Dismiss Denied
ORDER denying as moot 12 Motion to Dismiss. Signed by Judge Mitchell S. Goldberg on 9/26/2017. (fms) (Entered: 09/26/2017)
Entry #22 • 2017-09-26 Document →
Motion to Dismiss Pending / Under Review
STIPULATION TO EXTEND TIME Defendants Response to Plaintiffs' Motion to Dismiss Defendants' Counterclaims to 09/13/17 - filed by Aurobindo Pharma Ltd., Aurobind...
Entry #17 • 2017-09-06 Document →
Motion to Dismiss Pending / Under Review
SO ORDERED, re 17 STIPULATION TO EXTEND TIME Defendants Response to Plaintiffs' Motion to Dismiss Defendants' Counterclaims to 09/13/17 filed by Aurobindo Pharm...
Entry #18 • 2017-09-06 Document →

Docket Entries

(158 total)
Pleading / Complaint

COMPLAINT for PATENT INFRINGEMENT filed against Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2072385.) - filed by Shionogi Inc., Andrx Labs, L.L.C.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(nmg) (Entered: 01/26/2017)

Entry #1 • 2017-01-25
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) (Entered: 01/26/2017)

Entry #2 • 2017-01-25
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 12/12/2016. Date of Expiration of Patent: 3/17/2021.Thirty Month Stay Deadline: 6/12/2019. (nmg) (Entered: 01/26/2017)

Entry #3 • 2017-01-25
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,790,459; 6,866,866. (nmg) (Entered: 01/26/2017)

Entry #4 • 2017-01-25
1

Summons Issued with Magistrate Consent Notice attached as to Aurobindo Pharma Ltd. on 1/26/2017; Aurobindo Pharma USA, Inc. on 1/26/2017. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmg)

Entry #5 • 2017-01-25
1
No Actions

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc